Table 4.
Pharmacological activities of podophyllotoxin and its derivatives.
Activity | Podophyllotoxin Derivative | Mechanism | Conclusion | Ref. |
---|---|---|---|---|
Cytotoxic activity | Cleistantoxin | Activity was checked against MCF-7, MCF-7R, KBand HT29 cancer cell lines | Cleistantoxin showed strong cytotoxic activity | [146] |
Antibacterial activity | New precursors of podophyllotoxin were synthesized, and screened to check their antibacterial activity | Activity was checked against Klebsiella pneumoniae, Streptococcus faecalis, Citrobacter sp., Pseudomonas aeruginosa, Escherchia coli, Salmonella typhi and Shigella sonnei | Ethyl-2-(3′-methyl-4′-methoxybenzoyl)-3-(4″ methoxyphenol)-cyclopropane-1-carboxylic acid and Ethyl-2-(3′-methyl-4′-methoxybenzyol-3-1 3″, 4″-dimethoxyphenyl)-cyclopropane-carboxylic acid, both of them showed significant antibacterial activity | [147] |
Antitumour activity | VP 16-213 (NSC-141540) | Activity was checked against L1210 ascites tumour in N/D mice | In 24 hours, divided treatment after every 3 hours, resulted in significant cure, hence, VP 16-213 is a cell cycle specific drug | [148] |
Insecticidal activity | 20 podophyllotoxin analogues were tested | Activity was checked against fifth-instar larvae of Brontispa longissima in vivo | Among 20 analogues Deoxypodophyllotoxin showed more protential for insecticidal activity than a commercial insecticide (toosendanin) | [149] |
Antineoplastic activity | New hybrids of podophyllotoxin and indirubin | Activity was checked against human leukemia cancer cells as a multifunctional anti-MDR agent | Podophyllotoxin-indirubin hybrid (Da-1) showed potential to overcome drug resistance. It is a novel hybrid havingpotent antiproliferative activity | [150] |
Cyclolignans, derived from podophyllotoxin | Activity was checked againstA-549 human lung carcinoma, P-388 murine leukemia and HT-29 colon carcinoma | A number of substances were active in assay at concentrations below 1 pM; deoxypodophyllotoxin being the most potent compound in all cases | [151] |